NanoString Technologies (NSTG) Misses Q1 EPS by 23c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
NanoString Technologies Releases Financial Results for First Quarter of 2015
May 6, 2015 4:01 PM EDTStrong Q1 2015 Revenue Growth of 32% Year over Year
Cancer Focus Intensified With Recent Cancer Immunotherapy Trials Network and MD Anderson Collaborations and Innovative New Products Including Expanded Offerings in Immuno-Oncology
SEATTLE, May 6, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq: NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the first quarter ended March 31, 2015.
First Quarter Financial Highlights:
Total revenue of $11.6 million, 32% year-over-year growth Instrument revenue of $4.4 million, 27% year-over-year... More